1. Home
  2. RVNC vs CYD Comparison

RVNC vs CYD Comparison

Compare RVNC & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • CYD
  • Stock Information
  • Founded
  • RVNC 1999
  • CYD 1951
  • Country
  • RVNC United States
  • CYD Singapore
  • Employees
  • RVNC N/A
  • CYD N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • CYD Industrial Machinery/Components
  • Sector
  • RVNC Health Care
  • CYD Industrials
  • Exchange
  • RVNC Nasdaq
  • CYD Nasdaq
  • Market Cap
  • RVNC 320.5M
  • CYD 379.3M
  • IPO Year
  • RVNC 2014
  • CYD 1994
  • Fundamental
  • Price
  • RVNC $3.67
  • CYD $11.92
  • Analyst Decision
  • RVNC Hold
  • CYD
  • Analyst Count
  • RVNC 9
  • CYD 0
  • Target Price
  • RVNC $7.78
  • CYD N/A
  • AVG Volume (30 Days)
  • RVNC 2.9M
  • CYD 86.4K
  • Earning Date
  • RVNC 02-26-2025
  • CYD 02-25-2025
  • Dividend Yield
  • RVNC N/A
  • CYD 3.23%
  • EPS Growth
  • RVNC N/A
  • CYD 14.53
  • EPS
  • RVNC N/A
  • CYD 1.17
  • Revenue
  • RVNC $256,945,000.00
  • CYD $2,639,608,357.00
  • Revenue This Year
  • RVNC $11.28
  • CYD $11.68
  • Revenue Next Year
  • RVNC $27.21
  • CYD $4.06
  • P/E Ratio
  • RVNC N/A
  • CYD $8.87
  • Revenue Growth
  • RVNC 25.82
  • CYD 15.32
  • 52 Week Low
  • RVNC $2.30
  • CYD $7.95
  • 52 Week High
  • RVNC $7.56
  • CYD $13.05
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 61.28
  • CYD 68.91
  • Support Level
  • RVNC $3.25
  • CYD $9.90
  • Resistance Level
  • RVNC $3.70
  • CYD $10.68
  • Average True Range (ATR)
  • RVNC 0.08
  • CYD 0.67
  • MACD
  • RVNC 0.09
  • CYD 0.13
  • Stochastic Oscillator
  • RVNC 95.52
  • CYD 90.42

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: